Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Single-Agent Ibrutinib Versus Real-World (RW) Treatments for Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL): Adjusted Comparison of Resonate-2™ with the Cllear and Lyon-Sud Rw Databases

Michael Doubek, Mudr. Lukas Smolej, Martin Šimkovič, Anna Panovska, Renata Urbanova, Daniel Lysak, Evelyne Callet-Bauchu, Emmanuel Bachy, Lucile Baseggio, Emmanuelle Ferrant, Joris Diels, Jedelyn Cabrieto, Lasse Nielsen, Gilles Salles

Blood (2021) 138 (Supplement 1): 4679.

https://doi.org/10.1182/blood-2021-147927

Published: 2021

Journal Articles

Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53

Blood (2019) 134 (21): 1821–1831.

https://doi.org/10.1182/blood.2019001187

Published: 2019

Includes: Supplemental data

Journal Articles

Single-Agent Ibrutinib vs Real-World (RW) Treatments for Patients with Chronic Lymphocytic Leukemia (CLL) and del11q: Adjusted Comparison of RESONATE-2 TM and RESONATE TM with RW Databases

Gilles Andre Salles, MD, Evelyne Callet-Bauchu, Hervé Besson, Margaret Doyle, Jamie Garside, Martin Spacek, Michael Doubek, MD PhD

Blood (2018) 132 (Supplement 1): 4427.

https://doi.org/10.1182/blood-2018-99-112172

Published: 2018

Journal Articles

Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities. on Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group

Blood (2018) 132 (Supplement 1): 943.

https://doi.org/10.1182/blood-2018-99-115085

Published: 2018

Journal Articles

Single-Agent Ibrutinib Versus Real-World Treatments for Patients with Treatment-Naïve Chronic Lymphocytic Leukemia: Adjusted Comparison of Resonate-2™ with Real-World Databases

Gilles Salles, MD PhD, Lukas Smolej, MD PhD, Emmanuel Bachy, Lucile Baseggio, MD, Hervé Besson, Ruben Hermans, Nollaig Healy, Jamie Garside, Wafae Iraqi, Joris Diels, Finlay MacDougall, Corinna Pick-Lauer, Martin Spacek, Renata Urbanova, Daniel Lysak, Evelyne Callet-Bauchu, Michael Doubek, MD PhD

Blood (2017) 130 (Supplement 1): 5342.

https://doi.org/10.1182/blood.V130.Suppl_1.5342.5342

Published: 2017

Journal Articles

Absence of driver mutations in persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes

Bruno Tesson, Sarah Huet, Béatrice Grange, Laurent Jallades, Lucile Baseggio, Pascale Felman, Alexandra Traverse-Glehen, Jean-Pierre Magaud, Jean-Christophe Lega, Christine Bole-Feysot, Gilles Salles, Evelyne Callet-Bauchu, Pierre Sujobert

Blood (2017) 130 (10): 1267–1269.

https://doi.org/10.1182/blood-2017-03-776674

Published: 2017

Includes: Supplemental data

Journal Articles

Comprehensive analysis of a myeloperoxidase-negative acute promyelocytic leukemia

Maël Heiblig, Etienne Paubelle, Adriana Plesa, Marie-Oldine Geay, Delphine Manzoni, Sophie Gazzo, Isabelle Tigaud, Evelyne Callet-Bauchu, Sarah Huet, Gilles Salles, Xavier Thomas, Sandrine Hayette, Pierre Sujobert

Blood (2017) 129 (1): 128–131.

https://doi.org/10.1182/blood-2016-09-741355

Published: 2017

Journal Articles

Single-Agent Ibrutinib Vs Standard of Care for Patients with Relapsed/Refractory (R/R) and Treatment-Naive (TN) Chronic Lymphocytic Leukemia (CLL): An Adjusted Comparison of RESONATE TM and RESONATE-2 TM with the French Lyon-Sud Database

Gilles A. Salles, Lucile Baseggio, PharmD, PhD, Emmanuel Bachy, MD PhD, Clementine Sarkozy, MD, Herve Ghesquieres, MD PhD, Joris Diels, PhD, Hervé Besson, PhD, Finlay MacDougall, BA, Ruben Hermans, PhD MSc, Nollaig Healy, PhD, Jamie Garside, MSc, Wafae Iraqi, PharmD, PhD, Evelyne Callet-Bauchu, MD PhD

Blood (2016) 128 (22): 2039.

https://doi.org/10.1182/blood.V128.22.2039.2039

Published: 2016

Journal Articles

Toll-Like Receptor Profiles In Splenic Marginal Zone B-Cell Lymphoma and Splenic Diffuse Red Pulp B-Cell Lymphoma

Aurélie Verney, Alexandra Traverse-Glehen, Evelyne Callet-Bauchu, MD, PhD, Francoise Berger, Laurent Jallades, jean-Pierre Magaud, Pascale Felman, Gilles Andre Salles, MD, PhD, Lucile Baseggio

Blood (2013) 122 (21): 3009.

https://doi.org/10.1182/blood.V122.21.3009.3009

Published: 2013

Journal Articles

Detection of Leukemic Phase in Patients with Follicular Lymphoma At Diagnosis: A Rare Event Associated with Poor Prognosis

Clémentine Sarkozy, MD, Lucile Baseggio, MD, PhD, Evelyne Callet-Bauchu, MD, PhD, Lionel Karlin, MD, Laure L Lebras, MD, Anne-Sophie Michallet, MD, PhD, Olivier Dumas, MD, Alexandra Traverse-Glehen, MD, PhD, Francoise Berger, MD, Bertrand Coiffier, MD, PhD, Pascale Felman, MD, PhD, Gilles Salles, MD

Blood (2012) 120 (21): 1594.

https://doi.org/10.1182/blood.V120.21.1594.1594

Published: 2012

Journal Articles

Cytogenetic Abnormalities In a Cohort of 171 Patients with Waldenström Macroglobulinemia Before Treatment: Clinical and Biological Correlations

Blood (2010) 116 (21): 801.

https://doi.org/10.1182/blood.V116.21.801.801

Published: 2010

Journal Articles

Specific Chromosomal IG Translocations Have Different Prognosis In Chronic Lymphocytic Leukemia

Blood (2010) 116 (21): 582.

https://doi.org/10.1182/blood.V116.21.582.582

Published: 2010

Journal Articles

Deregulation of the telomerase reverse transcriptase ( TERT ) gene by chromosomal translocations in B-cell malignancies

Inga Nagel, Monika Szczepanowski, José I. Martín-Subero, Lana Harder, Takashi Akasaka, Ole Ammerpohl, Evelyne Callet-Bauchu, Randy D. Gascoyne, Stefan Gesk, Doug Horsman, Wolfram Klapper, Aneela Majid, José A. Martinez-Climent, Stephan Stilgenbauer, Holger Tönnies, Martin J. S. Dyer, Reiner Siebert

Blood (2010) 116 (8): 1317–1320.

https://doi.org/10.1182/blood-2009-09-240440

Published: 2010

Includes: Supplemental data

Journal Articles

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

Blood (2010) 115 (16): 3215–3223.

https://doi.org/10.1182/blood-2009-06-230250

Published: 2010

Includes: Supplemental data

Journal Articles

The t(14;18)(q32;q21)/ IGH-MALT1 translocation in MALT lymphomas contains templated nucleotide insertions and a major breakpoint region similar to follicular and mantle cell lymphoma

Eva Maria Murga Penas, Evelyne Callet-Bauchu, Hongtao Ye, Sophie Gazzo, Françoise Berger, Georgia Schilling, Nadine Albert-Konetzny, Eik Vettorazzi, Gilles Salles, Iwona Wlodarska, Ming-Qing Du, Carsten Bokemeyer, Judith Dierlamm

Blood (2010) 115 (11): 2214–2219.

https://doi.org/10.1182/blood-2009-08-236265

Published: 2010

Journal Articles

Molecular Characterization of the T(14;18)(q32;q21) Involving the IGH Locus and the MALT1 Gene in MALT Lymphomas

Eva Maria Murga Penas, Evelyne Callet-Bauchu, Nadine Albert, Sophie Gazzo, Françoise Berger, Gilles Salles, Carsten Bokemeyer, Judith Dierlamm

Blood (2008) 112 (11): 4145.

https://doi.org/10.1182/blood.V112.11.4145.4145

Published: 2008

Journal Articles

Deletions of Chromosomes 6q and 13q, and Trisomy 4 Are the Most Common Cytogenetic Abnormalities in Waldenstrom Macroglobulinemia. Preliminary Results of a Multicentric Study.

Blood (2008) 112 (11): 1771.

https://doi.org/10.1182/blood.V112.11.1771.1771

Published: 2008

Journal Articles

Indolent Mantle Cell Lymphoma (MCL): A Retrospective Detailed Clinical and Morphological Analysis of 21 Patients, with Histological, Cytological, Cytogenetic, Interphase Genetic, Immunoglobulin Gene, and Gene Expression Profiling Analysis.

Catherine Thieblemont, Remi Houlgatte, Pascale Felman, Alexandra Traverse-glehen, Lucile Baseggio, Delphine Rolland, Evelyne Callet-Bauchu, Gilles Salles, Francoise Berger, Bertrand Coiffier

Blood (2008) 112 (11): 1780.

https://doi.org/10.1182/blood.V112.11.1780.1780

Published: 2008

Journal Articles

Mir-21 Is Over Expressed in Aggressive SMZL

Marie Bouteloup, Aurélie Verney, Lucile Baseggio, PhD, Evelyne Callet-Bauchu, MD, PhD, Pascale Felman, MD, Martine Ffrench, MD, PhD, Bertrand Coiffier, MD, Jean-Pierre Magaud, MD, PhD, Francoise Berger, MD, PhD, Gilles Andre Salles, MD, PhD, Alexandra Traverse-Glehen, MD, PhD

Blood (2008) 112 (11): 624.

https://doi.org/10.1182/blood.V112.11.624.624

Published: 2008

Journal Articles

Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia

Delphine Poncet, Aurélie Belleville, Claire t'Kint de Roodenbeke, Aude Roborel de Climens, Elsa Ben Simon, Hélène Merle-Beral, Evelyne Callet-Bauchu, Gilles Salles, Laure Sabatier, Jozo Delic, Eric Gilson

Blood (2008) 111 (4): 2388–2391.

https://doi.org/10.1182/blood-2007-09-111245

Published: 2008

NARROW

Single-Agent Ibrutinib Versus Real-World (RW) Treatments for Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL): Adjusted Comparison of Resonate-2™ with the Cllear and Lyon-Sud Rw Databases

Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53

Single-Agent Ibrutinib vs Real-World (RW) Treatments for Patients with Chronic Lymphocytic Leukemia (CLL) and del11q: Adjusted Comparison of RESONATE-2 TM and RESONATE TM with RW Databases

Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities. on Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group

Single-Agent Ibrutinib Versus Real-World Treatments for Patients with Treatment-Naïve Chronic Lymphocytic Leukemia: Adjusted Comparison of Resonate-2™ with Real-World Databases

Absence of driver mutations in persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes

Comprehensive analysis of a myeloperoxidase-negative acute promyelocytic leukemia

Single-Agent Ibrutinib Vs Standard of Care for Patients with Relapsed/Refractory (R/R) and Treatment-Naive (TN) Chronic Lymphocytic Leukemia (CLL): An Adjusted Comparison of RESONATE TM and RESONATE-2 TM with the French Lyon-Sud Database

Toll-Like Receptor Profiles In Splenic Marginal Zone B-Cell Lymphoma and Splenic Diffuse Red Pulp B-Cell Lymphoma

Detection of Leukemic Phase in Patients with Follicular Lymphoma At Diagnosis: A Rare Event Associated with Poor Prognosis

Cytogenetic Abnormalities In a Cohort of 171 Patients with Waldenström Macroglobulinemia Before Treatment: Clinical and Biological Correlations

Specific Chromosomal IG Translocations Have Different Prognosis In Chronic Lymphocytic Leukemia

Deregulation of the telomerase reverse transcriptase ( TERT ) gene by chromosomal translocations in B-cell malignancies

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

The t(14;18)(q32;q21)/ IGH-MALT1 translocation in MALT lymphomas contains templated nucleotide insertions and a major breakpoint region similar to follicular and mantle cell lymphoma

Molecular Characterization of the T(14;18)(q32;q21) Involving the IGH Locus and the MALT1 Gene in MALT Lymphomas

Deletions of Chromosomes 6q and 13q, and Trisomy 4 Are the Most Common Cytogenetic Abnormalities in Waldenstrom Macroglobulinemia. Preliminary Results of a Multicentric Study.

Indolent Mantle Cell Lymphoma (MCL): A Retrospective Detailed Clinical and Morphological Analysis of 21 Patients, with Histological, Cytological, Cytogenetic, Interphase Genetic, Immunoglobulin Gene, and Gene Expression Profiling Analysis.

Mir-21 Is Over Expressed in Aggressive SMZL

Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only